ClinicalTrials.gg
TerminatedNCT03276741Updated Apr 24, 2020

Oral Intake During Labor

An interventional study of gastric soft/bland diet in Labor Complication, Food Aspiration and Complication of Anesthesia, sponsored by David Grant U.S. Air Force Medical Center. Terminated at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-04-24.

Sponsored by David Grant U.S. Air Force Medical Center · Not applicable, Interventional, and Supportive care

Why this study was terminated
Unable to recruit to enrollment target
Phase
Not applicable
Study type
Interventional
Enrollment
126
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

A randomized clinical trial (RCT) to evaluate the impact of unrestricted low fat, low residue oral intake during labor on maternal and neonatal outcomes as well as maternal satisfaction.

Read the detailed description

This study is a quantitative, randomized experimental design study to determine the impact of unrestricted low fat, low residue oral intake during labor on the indicated outcome variables and patient satisfaction. The comparison group will continue standard care of being allowed a clear liquid during active labor (≥6cm dilation), while the experimental group would be allowed to self-regulate oral intake with a low fat, low residue diet during active labor.

02

Conditions studied

  • Labor Complication
  • Food Aspiration
  • Complication of Anesthesia
  • Satisfaction

Keywords

  • labor
  • anesthesia
  • oral intake
  • maternal satisfaction
  • newborn complications
03

In context

Obstetric Labor Complications

88 studies on the registry are indexed under Obstetric Labor Complications; 24 are open to participants now.

This study's enrollment of 126 is below the median of 159 across 63 interventional studies indexed under Obstetric Labor Complications.

Browse Obstetric Labor Complications studies →

Lead sponsor

David Grant U.S. Air Force Medical Center is the lead sponsor of 28 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Active Duty and Department of Defense (DoD) beneficiary Pregnant women 18 years of age and older
  • 37 weeks gestation or greater at time of admission
  • singleton fetus
  • cephalic presentation
  • who plan to labor/deliver at DGMC (military beneficiaries).

Exclusion criteria

Exclusion Criteria:

  • Morbid/severe obesity (pre-pregnancy ≥40 kg/m2
  • diabetes
  • hypertension (to include pre-eclampsia or eclampsia)
  • previous cesarean section
  • uncontrolled gastroesophageal reflux disease (GERD) (symptomatic with medication)
  • past history or current diagnosis of hyperemesis gravidarum
  • food allergies to any items contained in the gastric/soft bland diet
  • patients utilizing nitrous oxide for labor analgesia (should this treatment be available at DGMC)
  • Difficult airway as defined by the anesthesia staff.
  • Mallampati score 3 or 4
  • Thyroid mental distance less than 7 cm or 3 finger breaths
  • Mouth opening less than 3 finger breaths
  • Short thick neck, Micrognathia
  • Further indications as determined by the anesthesia provider doing the anesthesia preoperative assessment (pregnancy in and of itself will not be considered a disqualification due to airway changes during labor)" in order to define difficult airway per anesthesia.
  • Under age 18
  • Additional clinical risk factors as determined by the care provider
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
126 participants (actual)

Study arms

  • No intervention
    Control Group

    Routine care during labor (authorized clear liquid diet).

  • Active comparator
    Experimental Group

    Patients in the experimental group will have a gastric soft/bland diet available, which will include lean protein, fruits, vegetables, and low-fat dairy. This will be ordered in the electronic medical record (EMR) and is a standard "non-select meal," referred to as a gastric/soft bland diet that is not based on patient's preferred menu selections.

    Dietary Supplement: gastric soft/bland diet

Interventions

  • Dietary supplementgastric soft/bland diet

    Patients in the experimental group will have a gastric soft/bland diet available.

06

What researchers measure

Primary outcomes

  1. Nausea

    # episodes

    Time frame: active labor (6cm or greater dilation) through delivery of the infant

  2. Vomiting

    # episodes

    Time frame: active labor (6cm or greater dilation) through delivery of the infant

  3. Duration of labor

    #hours/minutes

    Time frame: active labor (6cm or greater dilation) through delivery of the infant

  4. Mode of delivery

    cesarean section, operative vaginal delivery, spontaneous vaginal delivery

    Time frame: at birth

  5. Aspiration

    # episodes

    Time frame: active labor (6cm or greater dilation) through delivery of the infant

  6. Newborn APGAR Score

    \< 7

    Time frame: 5 min of life

  7. Maternal Satisfaction

    open ended survey question

    Time frame: active labor (6cm or greater dilation) through delivery of the infant

07

Study locations

1 site
  • USAF David Grant Medical Center
    Travis Air Force Base, California 94535, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2017 to primary completion in Jan 2020, 27 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2017
First posted
Sep 8, 2017
StartActual
Sep 29, 2017
Primary completionActual
Jan 11, 2020
CompletionActual
Jan 11, 2020
Last update
Apr 24, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03276741
Lead sponsor
David Grant U.S. Air Force Medical Center
Responsible party
Jeanette Anderson (Branch Chief, Provision of Inpatient Nursing Care, David Grant U.S. Air Force Medical Center) — Principal investigator
First posted
Sep 8, 2017
Start date
Sep 29, 2017
Primary completion
Jan 11, 2020
Completion
Jan 11, 2020
Last update
Apr 24, 2020

Study contacts

Jeanette M Anderson, MSN
principal investigator · David Grant Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion